Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

New Incentive Plan

12 Oct 2016 11:00

RNS Number : 1120M
Galliford Try PLC
12 October 2016
 

Galliford Try plc

(the "Company")

 

Proposed performance conditions for first awards under new Long Term Incentive Plan (the "Plan")

 

The Company intends to make its first awards under a new long-term incentive plan shortly following and contingent on shareholder approval at the 2016 Annual General Meeting for the new Plan.

 

The Company can now confirm that the performance conditions proposed for such first awards will be structured as previous grants and comprise measures of earnings per share ("EPS") and total shareholder return ("TSR") in respect of a performance period comprising three consecutive financial years of the Company starting with the current year ending 30 June 2017.

 

The vesting of up to 50% of each base award will be based on EPS performance, 15% of the base award will vest for aggregate EPS of 489 pence over the performance period, increasing to 50% of each base award vesting for aggregate EPS of 568 pence.

 

7.5% of each base award will vest for the Company's TSR performance against a Housebuilding Comparator Group ranking equal to median performance, increasing to 25% vesting of each base award if the Company's TSR is 24% higher than that of the median ranked company in such comparator group.

 

Vesting for relative TSR performance against the Housebuilding Comparator Group can increase to a maximum of 75% of each base award for the Company achieving a TSR that is 75% higher than the median ranked comparator company. Any vesting above 25% of each base award in relation to such TSR however also requires the maximum EPS target noted above to have been achieved.

 

The vesting of up to 75% of each base award will be based on the Company's TSR performance over the performance period relative to the TSRs over the same period of the companies within a Construction Comparator Group. Vesting under such measure will be calculated on the same basis as described above in relation to the Housebuilding Comparator Group but by reference to the Construction Comparator Group.

 

In aggregate 200% of each base award may vest subject to the terms and conditions of the Plan.

 

Housebuilding Comparator Group:

 

Barratt Developments plc, Bellway plc, Bovis Homes Group plc, Countryside plc, Crest Nicholson Holdings plc, McCarthy & Stone plc, M J Gleeson Group plc, Persimmon plc, Redrow plc, Taylor Wimpey plc and The Berkeley Group Holdings plc.

 

Construction Comparator Group:

 

Balfour Beatty plc, Carillion plc, Kier Group plc, Morgan Sindall Group plc, Costain Group plc, Keller Group plc and Henry Boot plc.

 

For further enquiries:

 

Galliford Try plc

Kevin Corbett, Company Secretary

01895 855001

Clara Melia, Investor Relations

07748 171 236

Tulchan Communications

James Macey White

0207 353 4200

Martin Pengelley

Matt Low

 

 

 

Galliford Try plc is a leading UK housebuilding and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes and Galliford Try Partnerships and Regeneration businesses - sells distinctive homes to the public and affordable homes to housing associations and local authority providers. The construction business carries out building and infrastructure work across the UK with clients ranging from major Government departments through to regulated utilities and private sector companies. At the end of the last financial year to 30 June 2016, the Group generated revenues of £2.5 billion.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKBLBFQBFXFBB
Date   Source Headline
17th Nov 20237:00 amRNSCompletion of Share Buyback Programme
16th Nov 20234:30 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20233:00 pmRNSResult of AGM
10th Nov 20237:00 amRNSAGM Statement
9th Nov 20237:00 amRNSAcquisition
8th Nov 20237:00 amRNSDirectorate Change
7th Nov 20237:00 amRNSContract
2nd Nov 20235:51 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20239:14 amRNSTransaction in Own Shares
23rd Oct 202311:05 amRNSDirectorate Change
18th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20233:30 pmRNSAnnual Financial Report
3rd Oct 202310:15 amRNSEmployee Share Trust Trading Plan
2nd Oct 202310:30 amRNSTotal Voting Rights
28th Sep 20233:05 pmRNSDirector/PDMR Shareholding
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20234:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSHolding(s) in Company
21st Sep 20232:30 pmRNSBlock listing Interim Review
20th Sep 20237:00 amRNSFinal Results
12th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 202311:00 amRNSAppointment of Joint Broker
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20232:00 pmRNSHolding(s) in Company
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSContract
7th Aug 20235:16 pmRNSHolding(s) in Company
7th Aug 20232:00 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 202310:00 amRNSTotal Voting Rights
14th Jul 20237:00 amRNSContract
11th Jul 20237:10 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTrading Statement
7th Jul 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.